Overview Financials News + Filings Key Docs Charts Ownership
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
TITAN MEDICAL INC (TMD)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/17/2021 |
6-K
| Quarterly results |
11/16/2020 |
6-K
| Quarterly results |
08/12/2020 |
6-K
| Quarterly results |
05/14/2020 |
6-K
| Quarterly results
Docs:
|
"TITAN MEDICAL INC. 6-K",
"Titan Medical Reports First Quarter 2020 Financial Results",
"Interim Financial Statements – March 31,2020",
"MANAGEMENT’S DISCUSSION AND ANALYSIS FOR THE THREE MONTHS ENDED MARCH 31, 2020",
"Review: I have reviewed the interim financial report and interim MD&A of Titan Medical Inc. for the interim period ended March 31, 2020. 2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. 3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performan...",
"Review:" |
|
05/15/2019 |
6-K
| Quarterly results
Docs:
|
"TITAN MEDICAL INC. 6-K",
"Titan Medical Reports First Quarter 2019 Financial Results",
"Unaudited Condensed Interim Financial Statements Three Months Ended March 31, 2019 and 2018",
"MANAGEMENT’S DISCUSSION AND ANALYSIS FOR THE THREE MONTHS ENDED MARCH 31, 2019 This Management’s Discussion and Analysis is dated May 14, 2019. This MD&A provides a review of the performance of Titan Medical Inc. and should be read in conjunction with its unaudited condensed interim financial statements for the three months ended March 31, 2019 and the annual audited financial statements for the years ended December 31, 2018 and 2017. The Interim Financial Statements have been prepared in accordance with International Financial Reporting Standards 34, Interim Financial Reporting . All financial figures are in United States Dollars except where otherwise noted. Internal Control over Financial Reporting During the three months ended March 31, 2019, no changes were made to the Company’s inte...",
"CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE",
"CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE" |
|
08/13/2018 |
6-K
| Quarterly results |
|
|